These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7577084)

  • 41. Gene marking after bone marrow transplantation.
    Brenner MK; Rill DR; Heslop HE; Rooney CM; Roberts WM; Li C; Nilson T; Krance RA
    Eur J Cancer; 1994; 30A(8):1171-6. PubMed ID: 7654451
    [No Abstract]   [Full Text] [Related]  

  • 42. Advances in the techniques and methodologies of cancer gene therapy.
    Sun W; Shi Q; Zhang H; Yang K; Ke Y; Wang Y; Qiao L
    Discov Med; 2019 Jan; 27(146):45-55. PubMed ID: 30721651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Saurabh Saha.
    Nat Rev Drug Discov; 2018 Jul; 17(8):538-539. PubMed ID: 30057409
    [No Abstract]   [Full Text] [Related]  

  • 44. From bench to community oncology clinic: the promise of immunotherapy.
    Chandra S
    Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP57-SP58. PubMed ID: 28298135
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells.
    Vile RG; Diaz RM; Castleden S; Chong H
    Biochem Soc Trans; 1997 May; 25(2):717-22. PubMed ID: 9191190
    [No Abstract]   [Full Text] [Related]  

  • 46. [A balance of clinical trials in gene therapy].
    Favrot MC; Coll JL; Puisieux I
    Bull Cancer; 1999 Jan; 86(1):115-21. PubMed ID: 10029714
    [No Abstract]   [Full Text] [Related]  

  • 47. Optimizing magnetic nanoparticle design for nanothermotherapy.
    Gazeau F; Lévy M; Wilhelm C
    Nanomedicine (Lond); 2008 Dec; 3(6):831-44. PubMed ID: 19025457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The contribution of marker gene studies to hemopoietic stem cell therapies.
    Brenner MK
    Stem Cells; 1995 Sep; 13(5):453-61. PubMed ID: 8528094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hematoprotection by transfer of drug-resistance genes.
    Flasshove M; Moritz T; Bardenheuer W; Seeber S
    Acta Haematol; 2003; 110(2-3):93-106. PubMed ID: 14583669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.
    Heslop H; Rooney C; Brenner M; Krance R; Carrum G; Gahn B; Bollard C; Khan S; Gee A; Popat U; Gresik M; Przepiorka D; Kuehnle I; Grilley B
    Hum Gene Ther; 2000 Jul; 11(10):1465-75. PubMed ID: 10910143
    [No Abstract]   [Full Text] [Related]  

  • 51. Cancer vaccines.
    Chekhun VF
    Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunotherapeutic strategies for neoplasia.
    Talmadge JE
    Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659
    [No Abstract]   [Full Text] [Related]  

  • 53. Gene Therapeutic Approaches to Overcome ABCB1-Mediated Drug Resistance.
    Lage H
    Recent Results Cancer Res; 2016; 209():87-94. PubMed ID: 28101689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging new anticancer therapies in 2013.
    Gomez-Roca C; Delord JP
    Curr Opin Oncol; 2014 May; 26(3):357-62. PubMed ID: 24709976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Translational medicine promising personalized therapy in oncology.
    Zeng YX; Zhang XS; Liu Q
    Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunotherapy for B-cell lymphoma.
    Nagler A; Shimoni A
    Leuk Lymphoma; 2010 Jan; 51(1):7-9. PubMed ID: 20055656
    [No Abstract]   [Full Text] [Related]  

  • 57. Trial watch: Burgeoning oncology pipeline raises questions about sustainability.
    Moser J; Verdin P
    Nat Rev Drug Discov; 2018 Oct; 17(10):698-699. PubMed ID: 30270348
    [No Abstract]   [Full Text] [Related]  

  • 58. Gene therapy for ovarian carcinoma.
    Robertson MW; Barnes MN; Rancourt C; Wang M; Grim J; Alvarez RD; Siegal GP; Curiel DT
    Semin Oncol; 1998 Jun; 25(3):397-406. PubMed ID: 9633852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From the editor. Bridging the gap between biostatistician and oncologist.
    Bates SE
    Clin Cancer Res; 2008 Oct; 14(19):5953. PubMed ID: 18829472
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunomodulatory gene therapy for haematological malignancies.
    Schmidt-Wolf GD; Schmidt-Wolf IG
    Br J Haematol; 2002 Apr; 117(1):23-32. PubMed ID: 11918529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.